Odyssean LLC’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
Odyssean LLC's RCUS Position: Q3 2026 in Review
Odyssean LLC increased its Arcus Biosciences (RCUS) stake by 82% in Q3 2026, buying an estimated $1.98M and bringing the position to 155,654 shares worth $4.02M. The position accounts for 0.46% of the portfolio, ranked #99.
Odyssean LLC first reported a position in RCUS in Q2 2026 and has held it in 2 quarters since. 244 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.
- Odyssean LLC held 155,654 shares of Arcus Biosciences worth $4.02M as of Q3 2026.
- Odyssean LLC bought 70,157 Arcus Biosciences shares in Q3 2026, an estimated $1.98M.
- Arcus Biosciences made up 0.46% of Odyssean LLC's portfolio in Q3 2026, its #99 holding.
- Odyssean LLC first reported a position in Arcus Biosciences in Q2 2026 and has held it in 2 quarters since.
- 244 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.
Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.